Press Release - Concept Medical
Press Release

Press Release

  • Concept Medical received IDE approval to investigate safety and efficacy of its Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease.

  • Concept Medical granted Investigational Device Exemption (IDE) approval for their Magic Touch Sirolimus Coated Balloon for the treatment of Below the Knee (BTK) Arterial Disease

  • Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

  • Sirolimus Coated Balloon in BTK Treatment makes a bold presence at VEITH 2022 – Lights up NY Times Square, NASDAQ

  • ABILITY DIABETES GLOBAL – A Landmark RCT in the field of PCI for patients with DM, completes Enrolment.

  • MagicTouch SCB receives IDE approval for In-Stent Restenosis indication.

  • TRANSFORM 1 Enrollment Completed: A Crucial RCT ready to redefine the DCB Angioplasty Mechanism

  • LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started

  • Best Exporter 2021-22

  • Well Begun AND Half Done! – SIRONA Randomized Trial Achieves fifty percent enrollment.

  • IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

  • Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling

  • ABILITY Diabetes Global enrolls thousandth patient: A Cardinal Milestone Achieved

  • SIRONA – The world’s first and largest RCT comparing Sirolimus V/S Paclitaxel balloon for the treatment of Peripheral Arterial Disease progresses rapidly.

  • International Women’s Day 2021

  • MagicTouch SCB Granted ‘Breakthrough Device Designation’ for the treatment of Small Coronary Artery Lesions.

  • Recurrent multi-metal layer ISR treated with MagicTouch-SCB

  • The world’s largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start.

  • Founders’ Day 2020

  • Do It For Your Heart | World Heart Day 2020

  • Concept Medical announces index patient enrolment in world’s first RCT with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease.

  • HIGH BLEEDING RISK AND CTO PATIENT

  • Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels

  • Enrolment initiated in World’s First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

  • PCI with Novel Sirolimus Eluting Stent

  • Sirolimus-eluting balloon is a valid treatment for vasculogenic erectile dysfunction

  • Concept Medical (MagicTouch PTA 0.035 OTW) receives CE Mark for treatment of peripheral artery disease.

  • IVUS guided PCI with MagicTouch SCB

  • OCT Follow-Up of Patients Treated for Significant stenosis of mid LAD | Abluminus DES+ | Sirolimus Eluting Stent

  • MagicTouch Sirolimus Coated Balloon Treatment in LAD with positive remodeling

  • Brand Vision 2020 | The Masterstroke | Republic TV

  • LINC 2020: XTOSI study interim findings suggest “highly promising” safety and efficacy of sirolimus DCB

  • Information given about the use of “Sirolimus Coated Balloon” at Unicare Heart Hospital By Dr. Sandeep Basavaraja and Dr. Dewang Desai.

  • Vasculogenic Erectile Dysfunction – Case by Prof. Sangiorgi – MagicTouch ED

  • Concept Medical is Granted CE Certification for Sirolimus Coated MagicTouch Group of Products.

  • Getting sued for €25M was the best thing to happen to this award-winning inventor

  • Concept Medical Inc. Raises $60mn for Investigational Device Exemption (IDE) for the World’s First Sirolimus-Coated Balloon

  • Economics Times Rising Indians 2019.

  • Concept Medical has created a niche for itself with its innovative drug-coated stent and balloon catheter for diabetic heart patients

  • Concept Medical Inc. Granted ‘Breakthrough Device Designation’ From FDA for Its MagicTouch Sirolimus Coated Balloon.

  • Concept Medical Granted “Breakthrough Device Designation” by FDA for MagicTouch PTA Sirolimus Coated Balloon

  • Concept Medical Inc. Granted ‘Breakthrough Device Designation’ From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

  • IMPRESSION – A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly.